Global Pharmaceutical Processing Equipment Market – Industry Trends and Forecast to 2031

Pharmaceutical Processing Equipment Market Analysis and Size

The global pharmaceutical processing equipment market is driven by global rise in chronic diseases such as cardiovascular diseases, cancer, and respiratory disorders is further increasing the demand for pharmaceutical products. However, one restraint for market growth is the raw material shortages are a major concern in pharmaceutical processing equipment manufacturing, as specialized materials may be scarce or hard to source, leading to production delays and higher costs. An opportunity in this market lies in the modern technologies such as automation, robotics, PAT, and continuous manufacturing enhance operational efficiency, reduce production costs, and boost product quality, presenting a significant market growth. One challenge is the high demand for specialized expertise makes it challenging for companies to recruit and retain qualified professionals, resulting in increased competition and higher labor costs.

Data Bridge Market Research analyzes that the global pharmaceutical processing equipment market is growing with a CAGR of 9.41% in the forecast period of 2024 to 2031 and is expected to reach USD 30,821.11 million by 2031 from USD 15,354.28 million in 2023.

Market Definition

Pharmaceutical processing equipment comprises a diverse range of specialized machinery and tools essential for the manufacturing, handling, and preparation of pharmaceutical products. This equipment is designed to meet stringent regulatory standards and ensure the safety, efficacy, and quality of pharmaceutical formulations. Key categories of pharmaceutical processing equipment include mixing and blending machines, which amalgamate active pharmaceutical ingredients (APIs) with excipients to create homogeneous mixtures. Milling and size reduction equipment reduces particle sizes of raw materials to achieve desired characteristics for further processing or formulation. Tablet compression and capsule filling machines automate the production of tablets and capsules, ensuring precise dosing and uniformity.

This equipment is pivotal in adhering to Good Manufacturing Practices (GMP) and regulatory requirements, enhancing efficiency and ensuring the consistency and safety of pharmaceutical products delivered to patients and healthcare providers.

Global Pharmaceutical Processing Equipment Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:

Drivers

• Increase Demand for Pharmaceutical Products

The growing demand for pharmaceutical products is driven by several factors, including a global population increase that requires more healthcare services and medications, leading to a greater need for pharmaceutical production to treat a range of health conditions.

The aging population, particularly in developed nations, is driving up the demand for pharmaceuticals. Elderly individuals typically require more medications to manage age-related ailments such as hypertension, diabetes, and arthritis. Consequently, this demographic change is driving the need for pharmaceuticals and, subsequently, pharmaceutical processing equipment.

• Growing Demand for High Containment Equipment

High containment equipment is essential in ensuring the safe handling and production of Highly Potent Active Pharmaceutical Ingredients (HPAPIs) and other hazardous substances. This demand is primarily driven by several key factors.

There is an increasing focus on developing and manufacturing specialty drugs, including those used in oncology, immunotherapy, and other treatments involving HPAPIs. These drugs require stringent safety measures to protect workers and the environment from exposure to hazardous substances during the manufacturing process. High containment equipment, such as isolators and barrier systems, provides the necessary level of protection and contamination control, making them indispensable in modern pharmaceutical production facilities

Opportunity

• Integration of Advanced Manufacturing Technologies

Advanced manufacturing technologies offer a transformative opportunity in the global pharmaceutical processing equipment market. Modern technologies such as automation, robots, Process Analytical Technology (PAT) and continuous manufacturing can be integrated to improve operational effectiveness, lower production costs, and improve product quality. Pharmaceutical firms can keep up with changing market demands, stay competitive, and encourages industry innovation by adopting these IoT, robotics and PAT technologies.

Restraint/Challenge

• Supply Chain Disruptions

Supply chain disruptions present a significant restraint for the global pharmaceutical processing equipment market. These disruptions can stem from various sources, including raw material shortages, logistics challenges, and geopolitical issues, all of which can impede the availability and timely delivery of essential equipment.

Raw material shortages are a primary concern. The manufacturing of pharmaceutical processing equipment often relies on specialized materials, which may be scarce or difficult to source. When the supply of these materials is interrupted, production delays and increased costs can ensue. For example, the availability of high-grade stainless steel, critical for its corrosion resistance and durability in pharmaceutical environments, can be affected by global supply constraints.

Recent Developments

• In November 2023, Thermo Fisher Scientific and Flagship Pioneering have partnered to develop and scale multiproduct platforms quickly. This collaboration aims to create new companies focusing on innovative tools for the biotech industry, leveraging the expertise of both organizations to accelerate therapy development
• In August 2023, Thermo Fisher Scientific has acquired CorEvitas, a provider of real-world evidence, to enhance its Laboratory Products and Biopharma Services segment. This acquisition strengthens Thermo Fisher's position in providing regulatory-grade data for medical treatments, contributing to its growth and innovation in the healthcare sector
• In January 2024, EcoDataCenter achieves an industry first by deploying Alfa Laval heat exchangers made from recycled steel, produced without new CO2 emissions from SSAB, marking a significant milestone in reducing carbon emissions and highlighting the importance of collaboration in sustainability efforts. This advancement will enhance the company's environmental reputation, reduce its carbon footprint, and set a new standard for sustainable practices in the industry
• In May 2024, GEA continues to expand its portfolio of pharmaceutical spray dryers. At ACHEMA in Frankfurt (June 10-14, 2024, Hall 4.0, Stand G66), GEA will present the new GEA ASEPTICSD spray dryers. They are specially designed for pharmaceutical spray drying applications. From antibiotics, vaccines, hormones and allergens to monoclonal antibodies, therapeutic peptides and proteins, blood products and powders for parenteral infusions, the spray dryers offer versatile solutions. The spray dryers can also be designed to handle organic solvents, allowing the use of a variety of carriers within the formulation
• In January 2024, SPX FLOW's Anhydro brand introduced the SmartDry System, utilizing advanced technology for precise control in variable production environments. This "Plug-and-Produce" system enhances automation, saving costs and optimizing production efficiency. This release enhances SPX FLOW's reputation for innovative solutions, attracting customers looking for advanced, automated systems to improve their spray drying processes, thereby increasing the company's market share and revenue

Global Pharmaceutical Processing Equipment Market Scope

Global pharmaceutical processing equipment market is segmented into six notable segments based on equipment, dosage type, processing type, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

Equipment

• Mixers
• Blenders
• Granulators
• Pumps
• Heat Exchangers
• Others

On the basis of equipment, the global pharmaceutical processing equipment market is segmented into mixers, blenders, granulators, pumps, heat exchangers, and others.

Dosage Type

• Solid Dosage Processing Equipment
• Liquid Dosage Processing Equipment
• Semi-Solid Dosage Processing Equipment

On the basis of dosage type, the global pharmaceutical processing equipment market is segmented into solid dosage processing equipment, liquid dosage processing equipment, and semi-solid dosage processing equipment.

Processing Type

• Upstream Processing
• Downstream Processing

On the basis of processing type, the global pharmaceutical processing equipment market is segmented into upstream processing and downstream processing.

Application

• Mixing & blending
• Granulation
• Drying
• Tablet compression
• Capsule filling
• Others

On the basis of application, the global pharmaceutical processing equipment market is segmented into mixing & blending, granulation, drying, tablet compression, capsule filling, and others.

End User

• Pharmaceutical & Biopharmaceutical Companies
• Contract Research Organization
• R&D Laboratories
• Others

On the basis of end user, the global pharmaceutical processing equipment market is segmented into pharmaceutical & biopharmaceutical companies, contract research organization, R&D laboratories, and others.

Distribution Channel

• Direct Tenders
• Retail Sales
• Others

On the basis of distribution channel, the global pharmaceutical processing equipment market is segmented into direct tenders, retail sales, and others.

Global Pharmaceutical Processing Equipment Market Regional Analysis/Insights

Global pharmaceutical processing equipment market is analyzed, and market size insights and trends are provided by based on equipment, dosage type, processing type, application, end user, and distribution channel.

The countries covered in this global pharmaceutical processing equipment market report are U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Belgium, Russia, Switzerland, Netherlands, Turkey, rest of Europe, China, Australia, Japan, India, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, and rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa.

North America is expected to dominate the market due to its advanced infrastructure, strong R&D capabilities, stringent regulatory standards, and significant investment in innovation and technology. U.S. is expected to dominate in the North America market due to advanced infrastructure, robust regulatory framework, extensive R&D investment, and significant market size.

U.K. is expected to dominate in the Europe market due to its strong regulatory standards, cutting-edge research institutions, strategic geographic location, and a history of innovation in pharmaceutical development.

China is expected to dominate in the Asia-Pacific market due to its lower manufacturing costs, expansive production capabilities, a large domestic market, and government support for industry growth.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Pharmaceutical Processing Equipment Market Share Analysis

Global pharmaceutical processing equipment market is segmented into six notable segments based on equipment, dosage type, processing type, application, end user, and distribution channel.

Global pharmaceutical processing equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the global pharmaceutical processing equipment market.

Some of the major players operating in the global pharmaceutical processing equipment market are Thermo Fisher Scientific Inc., ALFA LAVAL, GEA Group Aktiengsellschaft, SPX FLOW, Inc., I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A, ACG, Syntegon Technology GmbH, Paul Mueller Company, FREUND Corp., Gansons, Alexanderwerk AG, B&P Littleford, Chamunda Pharma Machinery, Prism Pharma Machinery, SaintyCo Nicomac Srl, United Pharmatek USA, ADINATH INTERNATIONAL, NU PHARMA ENGINEERS & CONSULTANT, and Senieer among others.

SKU-72588